share_log

FendX Announces Grant of Stock Options and RSUs

FendX Announces Grant of Stock Options and RSUs

FendX宣佈授予股票期權和限制性股票單位
newsfile ·  07/19 10:38

Oakville, Ontario--(Newsfile Corp. - July 18, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection coatings announces it has granted stock options and restricted share units ("RSUs") to certain directors, officers, employees and consultants.

安大略省奧克維爾--(Newsfile Corp.,2024年7月18日)——開發表面保護塗層的納米技術公司FendX Technologies Inc.(CSE:FNDX)(場外交易代碼:FDXTF)(FSE:E8D)(“公司” 或 “FendX”)宣佈已向某些董事、高級管理人員、員工和顧問授予股票期權和限制性股票單位(“RSU”)。

FendX granted an aggregate of 3,950,000 stock options to certain directors, officers, employees and consultants at an exercise price of $0.29 expiring five years from the date of grant. The stock options are subject to vesting provisions such that 50% of the options vest on the grant date and 25% vest on each of the dates that is nine and eighteen months from the date of grant. In addition, the Company granted an aggregate of 1,150,000 RSUs to two officers and a consultant. The RSUs vest as to 50% on the grant date and 25% on each of the dates that is nine and eighteen months from the date of grant. The stock options and RSUs were granted in accordance with the Company's equity incentive plan dated October 19, 2021. All of the stock options and RSUs are subject to a hold period of four months and one day from the date of grant.

FendX向某些董事、高級職員、僱員和顧問共授予了3950,000份股票期權,行使價爲0.29美元,自授予之日起五年內到期。股票期權受歸屬條款的約束,例如,50%的期權在授予之日歸屬,25%的期權在授予之日起九個月和十八個月的每個日期歸屬。此外,公司向兩名高管和一名顧問共授予了1150,000份限制性股票單位。自授予之日起九個月和十八個月後,限制性股權單位的授予權限爲50%,在每個日期(自授予之日起的九個月和十八個月)分配25%。股票期權和限制性股票單位是根據公司2021年10月19日的股權激勵計劃授予的。自授予之日起,所有股票期權和限制性股票單位的持有期爲四個月零一天。

None of the securities will be registered under the United States Securities Act of 1933, as amended (the "1933 Act"), and none of them may be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the 1933 Act. This news release shall not constitute an offer to sell or solicitation of an offer to buy nor shall there be any sale of the securities in any state where such offer, solicitation, or sale would be unlawful.

任何證券都不會根據經修訂的1933年《美國證券法》(“1933年法案”)進行註冊,如果沒有註冊或沒有1933年法案的註冊要求的適用豁免,任何證券都不得在美國發行或出售。本新聞稿不構成賣出要約或徵求買入要約,也不得在任何州出售證券,任何此類要約、招攬或出售爲非法的州。

About FendX Technologies Inc.

關於 FendX 科技公司

FendX is a Canada-based nanotechnology company focused on developing products to make people's lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with industry-leading partners, including McMaster University. The Company has exclusive worldwide licenses to its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.

FendX 是一家總部位於加拿大的納米技術公司,專注於開發產品,通過減少病原體的傳播,使人們的生活更安全。該公司正在開發薄膜和噴霧產品,以保護表面免受污染。正在開發的主要產品 REPELWRAP 薄膜是一種保護性表面塗層薄膜,由於其排斥特性,它可以防止病原體粘附並減少其在易受污染的表面上的傳播。噴霧納米技術是一種雙功能噴塗塗層,正在開發中,通過排斥和殺死病原體來減少表面污染。該公司正在與包括麥克馬斯特大學在內的行業領先合作伙伴合作,利用其納米技術開展研發活動。該公司擁有麥克馬斯特的技術和知識產權組合的全球獨家許可,其中包括薄膜和噴塗塗層納米技術配方。

ON BEHALF OF FENDX TECHNOLOGIES INC.

代表 FENDX TECHNOLOGIES INC.

"Carolyn Myers"
Carolyn Myers
Chief Executive Officer and Director

“卡羅琳·邁爾斯”
卡羅琳·邁爾斯
首席執行官兼董事

Contacts:

聯繫人:

Dr. Carolyn Myers, CEO and Director
1-800-344-9868
investor@fendxtech.com

首席執行官兼董事卡羅琳·邁爾斯博士
1-800-344-9868
investor@fendxtech.com

For more information, please visit and the Company's profile on SEDAR+ at .

欲了解更多信息,請訪問SEDAR+上的公司簡介,網址爲。

Neither the Canadian Securities Exchange nor the Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

加拿大證券交易所和市場監管機構(該術語在加拿大證券交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Forward-Looking Statements

前瞻性陳述

This news release contains certain forward-looking statements within the meaning of Canadian securities legislation, including with respect to: the plans of the Company; the Company's belief that REPELWRAP will have applications in healthcare settings and other industries; and products under development and any pathogen reduction benefits related thereto. Although the Company believes that such statements are reasonable, it can give no assurance that such expectations will prove to be correct. Forward-Looking statements are statements that are not historical facts; they are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "aims," "potential," "goal," "objective," "prospective," and similar expressions, or that events or conditions "will," "would," "may," "can," "could" or "should" occur, or are those statements, which, by their nature, refer to future events. The Company cautions that forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made, and they involve a number of risks and uncertainties. Consequently, there can be no assurances that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.

本新聞稿包含加拿大證券立法所指的某些前瞻性陳述,包括:公司的計劃;公司對REPELWRAP將在醫療機構和其他行業中應用的信念;以及正在開發的產品以及與之相關的任何病原體減少益處。儘管該公司認爲此類陳述是合理的,但它無法保證此類預期會被證明是正確的。前瞻性陳述是不是歷史事實的陳述;它們通常以 “期望”、“計劃”、“預期”、“相信”、“打算”、“估計”、“項目”、“目標”、“潛力”、“目標”、“目標”、“目標”、“前景” 和類似的表述來識別,或者事件或條件 “將”、“可能”、“可能”、“可能”、“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,“可能”,” “可能” 或 “應該” 出現,或者這些言論,就其性質而言,是指未來的事件。公司警告說,前瞻性陳述基於公司管理層在陳述發表之日的信念、估計和觀點,涉及許多風險和不確定性。因此,無法保證此類陳述會被證明是準確的,實際結果和未來事件可能與此類聲明中的預期有重大差異。

Important factors that could cause future results to differ materially from those anticipated in these forward-looking statements include: product candidates only being in formulation/reformulation stages; limited operating history; research and development activities; dependence on collaborative partners, licensors and others; effect of general economic and political conditions; and other risk factors set forth in the Company's public filings which are available on SEDAR+ at . The reader is urged to refer to such public filings for a more complete discussion of such risk factors and their potential effects. Except to the extent required by applicable securities laws and the policies of the Canadian Securities Exchange, the Company undertakes no obligation to update these forward-looking statements if management's beliefs, estimates or opinions, or other factors, should change.

可能導致未來業績與這些前瞻性陳述中的預期存在重大差異的重要因素包括:候選產品僅處於制定/重新制定階段;運營歷史有限;研發活動;對合作夥伴、許可方和其他人的依賴;總體經濟和政治狀況的影響;以及公司公開文件中列出的其他風險因素,這些文件可在SEDAR+上查閱。我們敦促讀者參考此類公開文件,以更全面地討論此類風險因素及其潛在影響。除非適用的證券法和加拿大證券交易所的政策有要求,否則如果管理層的信念、估計或觀點或其他因素髮生變化,公司沒有義務更新這些前瞻性陳述。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論